Sulbactam–Durlobactam for Carbapenem-Resistant Acinetobacter baumannii–calcoaceticus Complex
Pathogens · 2026
DOI: 10.3390/pathogens15040449 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, 2026. Verfasst von Francesco Nappi. Beteiligte Einrichtung: Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France. Hauptthemen laut MEDLINE: Sulbactam, Acinetobacter baumannii, Carbapenems, Acinetobacter Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Carbapenem-resistant Acinetobacter baumannii infections pose a significant challenge due to their severity and the poor prognoses they often result in, particularly in cases where there are risk factors present. The United States (US) Centers for Disease Control and Prevention (CDC) identified carbapenem-resistant Acinetobacter baumannii (CRAB) infections as a threat to human health. The World Health Organization (WHO) has classified it as a top priority for research. In 2023, the US FDA approved sulbactam–durlobactam for treating certain A. baumannii infections. As of 2024, this combination is designated as the preferred treatment strategy by the Infectious Diseases Society of America (IDSA) for infections due to carbapenem-resistant A. baumannii. In this therapeutic review, the preclinical and clinical data relevant to this regulatory decision were analyzed. This in-depth analysis will provide a comprehensive overview of the complex subject matter. It should be observed that carbapenem-based combination therapy is indicated for carbapenem-resistant A. baumannii.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France.
ORCID-Profile: Francesco Nappi
Zitieren
APA
Nappi, F. (2026). Sulbactam–Durlobactam for Carbapenem-Resistant Acinetobacter baumannii–calcoaceticus Complex. Pathogens. https://doi.org/10.3390/pathogens15040449
Vancouver
Nappi F. Sulbactam–Durlobactam for Carbapenem-Resistant Acinetobacter baumannii–calcoaceticus Complex. Pathogens. 2026. doi:10.3390/pathogens15040449
BibTeX
@article{Nappi2026,
author = {Nappi, Francesco},
title = {Sulbactam–Durlobactam for Carbapenem-Resistant Acinetobacter baumannii–calcoaceticus Complex},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15040449}
}
EUVIMED